• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心包炎和心包积液的诊断与治疗]

[Diagnostics and therapy of pericarditis and pericardial effusion].

作者信息

Maisch B, Ristić A D

机构信息

Fachbereich Medizin der Philipps-Universität Marburg, Feldbergstr. 45, 35043, Marburg, Deutschland,

出版信息

Herz. 2014 Nov;39(7):837-56. doi: 10.1007/s00059-014-4167-1.

DOI:10.1007/s00059-014-4167-1
PMID:25347952
Abstract

This article describes the diagnostics, differential diagnostics, multimodal imaging, medicinal and invasive diagnostic therapy of acute and chronic pericarditis, constrictive pericarditis, pericardial effusion and cardiac tamponade under etiological aspects and on the basis of the guidelines of the European Society of Cardiology (ESC). The starting point of the decision tree is the symptomatic patient with echocardiographic evidence of pericardial effusion. The principle feature of the diagnostics is the etiopathogenetic allocation of the pericardial disease which influences the clinical picture, course therapy and prognosis. Infectious pericarditis (e.g. viral, bacterial and tuberculous) is differentiated from sterile autoreactive pericarditis and from neoplastic pericardial effusion by the cytology of the effusion and immunohistological and molecular investigations of the pericardial and epicardial biopsies. Pericardioscopy plays an important role in the recognition of suspicious areas. In many cases intrapericardial administration of cisplatin for neoplastic pericardial effusion and instillation of triamcinolone for autoreactive pericarditis prevent recurrence just as a treatment of several months with colchicine.

摘要

本文依据欧洲心脏病学会(ESC)的指南,从病因学角度描述了急慢性心包炎、缩窄性心包炎、心包积液和心脏压塞的诊断、鉴别诊断、多模态成像、药物及侵入性诊断治疗。决策树的起点是有超声心动图证据显示心包积液的有症状患者。诊断的主要特征是心包疾病的病因病理分类,这会影响临床表现、病程治疗及预后。通过积液的细胞学检查以及心包和心外膜活检的免疫组织学和分子研究,可将感染性心包炎(如病毒性、细菌性和结核性)与无菌性自身反应性心包炎及肿瘤性心包积液区分开来。心包镜检查在识别可疑区域方面发挥着重要作用。在许多情况下,对于肿瘤性心包积液心包内注射顺铂以及对于自身反应性心包炎滴注曲安奈德可预防复发,就如同使用秋水仙碱治疗数月一样。

相似文献

1
[Diagnostics and therapy of pericarditis and pericardial effusion].[心包炎和心包积液的诊断与治疗]
Herz. 2014 Nov;39(7):837-56. doi: 10.1007/s00059-014-4167-1.
2
[Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis].[复发性自身反应性心包积液。心包炎病因分类的影响]
Dtsch Med Wochenschr. 2006 Sep 29;131(39):2143-6. doi: 10.1055/s-2006-951342.
3
European Guidelines on Pericardial Diseases: a Focused Review of Novel Aspects.《欧洲心包疾病指南:新进展重点综述》
Curr Cardiol Rep. 2016 May;18(5):46. doi: 10.1007/s11886-016-0721-1.
4
[Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].[心包炎和心包积液、缩窄性心包炎及渗出-缩窄性心包炎的管理]
Herz. 2018 Nov;43(7):663-678. doi: 10.1007/s00059-018-4744-9.
5
[New possibilities of diagnostics and therapy of pericarditis].[心包炎诊断与治疗的新可能性]
Internist (Berl). 2008 Jan;49(1):17-26. doi: 10.1007/s00108-007-1961-3.
6
[Progress or regress or both? ESC guidelines on pericardial diseases 2015].[是进步还是退步,抑或兼而有之?2015年欧洲心脏病学会心包疾病指南]
Herz. 2015 Dec;40(8):1061-9. doi: 10.1007/s00059-015-4395-z.
7
New directions in diagnosis and treatment of pericardial disease. A project of the Taskforce on Pericardial Disease of the World Heart Federation.心包疾病诊断与治疗的新方向。世界心脏联盟心包疾病特别工作组项目。
Herz. 2000 Dec;25(8):769-80. doi: 10.1007/pl00001996.
8
Pericardial diseases, with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods, and treatment.心包疾病,重点关注病因、发病机制、病理生理学、新的诊断成像方法及治疗。
Curr Opin Cardiol. 1994 May;9(3):379-88. doi: 10.1097/00001573-199405000-00017.
9
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).2015年欧洲心脏病学会(ESC)心包疾病诊断和管理指南:欧洲心脏病学会(ESC)心包疾病诊断和管理工作组 认可机构:欧洲心胸外科学会(EACTS)
Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29.
10
Pericardial syndromes: an update after the ESC guidelines 2004.心包综合征:2004 年 ESC 指南更新后
Heart Fail Rev. 2013 May;18(3):255-66. doi: 10.1007/s10741-012-9335-x.

引用本文的文献

1
[Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].[心包炎和心包积液、缩窄性心包炎及渗出-缩窄性心包炎的管理]
Herz. 2018 Nov;43(7):663-678. doi: 10.1007/s00059-018-4744-9.
2
[Progress or regress or both? ESC guidelines on pericardial diseases 2015].[是进步还是退步,抑或兼而有之?2015年欧洲心脏病学会心包疾病指南]
Herz. 2015 Dec;40(8):1061-9. doi: 10.1007/s00059-015-4395-z.
3
[Vasculitis : EULAR/ACR guidelines with respect to the clinical cardiological routine].[血管炎:欧洲抗风湿病联盟/美国风湿病学会关于临床心脏病学常规的指南]

本文引用的文献

1
European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease.欧洲心血管影像协会(EACVI)立场文件:心包疾病的多模态影像学。
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):12-31. doi: 10.1093/ehjci/jeu128. Epub 2014 Sep 23.
2
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.泼尼松龙和印度分枝杆菌在结核性心包炎中的应用。
N Engl J Med. 2014 Sep 18;371(12):1121-30. doi: 10.1056/NEJMoa1407380. Epub 2014 Sep 1.
3
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.
Herz. 2015 Feb;40(1):85-98. doi: 10.1007/s00059-014-4200-4.
4
Spontaneous fusion between cancer cells and endothelial cells.癌细胞与内皮细胞之间的自发融合。
Cell Mol Life Sci. 2004 Aug;61(16):2125-31. doi: 10.1007/s00018-004-4200-2.
秋水仙碱预防心包切开术后综合征和术后心房颤动:COPPS-2 随机临床试验。
JAMA. 2014 Sep 10;312(10):1016-23. doi: 10.1001/jama.2014.11026.
4
Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心脏压塞紧急处理的分诊策略:欧洲心脏病学会心肌和心包疾病工作组的立场声明
Eur Heart J. 2014 Sep 7;35(34):2279-84. doi: 10.1093/eurheartj/ehu217. Epub 2014 Jul 7.
5
Pericardial diseases in the era of imaging, biomarkers and molecular diagnosis.成像、生物标志物与分子诊断时代的心包疾病
Heart Fail Rev. 2013 May;18(3):251-4. doi: 10.1007/s10741-013-9386-7.
6
Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy.心包镜检查术、心外膜和心包活检术——打开心脏的新窗口,提高病因诊断水平,并能进行靶向性心包内治疗。
Heart Fail Rev. 2013 May;18(3):317-28. doi: 10.1007/s10741-013-9382-y.
7
Alcohol ablation of pericardial cysts under pericardioscopical control.心包囊肿内镜下酒精消融术。
Heart Fail Rev. 2013 May;18(3):361-5. doi: 10.1007/s10741-013-9383-x.
8
Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions.从德国大至中等心包积液患者的心包积液和心外膜及心内膜活检样本中检测到病毒基因组。
Heart Fail Rev. 2013 May;18(3):329-36. doi: 10.1007/s10741-013-9375-x.
9
Surgery for pericardial disease.心包疾病的外科治疗。
Heart Fail Rev. 2013 May;18(3):375-87. doi: 10.1007/s10741-012-9338-7.
10
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis.肿瘤性、自身免疫性和病毒性心包炎的心包细胞因子。
Heart Fail Rev. 2013 May;18(3):345-53. doi: 10.1007/s10741-012-9334-y.